For instance, anti-Jo-1 antibodies are associated with associated with classic DM skin lesions, while anti- TIF-1γ (27) and anti-NXP-22 antibodies are correlated with the risk of malignancy in DM. The gene discussed is TRIM33; the disease is dermatomyositis.